Biosecure Act hits turbulence

The Biosecure Act, which has floated through Congress, buoyed by bipartisan anti-China sentiment, protectionist impulses and concerns about supply chain vulnerabilities, has hit some turbulence. While the sense of inevitability has diminished, enactment this year of the Biosecure Act (H.R. 8333) or something like it is very likely.

The decision by the House Rules Committee Tuesday to exclude the legislation from the must-pass National Defense Authorization Act (NDAA) closed off the smoothest path to President Joe Biden’s desk. ...